Premier Research, a clinical research company, has named Cassandra Matney, MD as its new senior medical director, it was reported on Monday.
Matney has experience in both solid and haemato-oncology tumours. Her therapeutic work in haematology and oncology includes prostate cancer, acute myeloid leukaemia, multiple myeloma, myeloproliferative neoplasms, myelodysplastic syndromes, B-cell malignancies, urothelial/bladder cancer, gastric/gastroesophageal cancer, and graft versus host disease.
Most recently, Matney managed medical affairs positions at Astellas Pharmaceuticals Global Development Inc, Janssen Oncology (a pharmaceutical company of Johnson & Johnson), and Incyte Corporation. She has also served as CRO and has site experience working at both Covance and academic centre Meharry Medical College, respectively.
Matney holds a medical degree at the Universidad Autonoma de Guadalajara and New York Medical College, and a Bachelor of Science degree from Illinois State University. She is certified by the Educational Commission for Foreign Medical Graduates.
AmacaThera named Life Sciences Ontario Emerging Company of the Year
GenSight Biologics reports first patient treated in GS010 REVISE study
Biophytis secures Asian partnership and investment to advance Phase 3 sarcopenia programme
MemorialCare hospitals recognised in 2026 Women's Choice Awards
Champions Oncology expands bioanalytical services with new technology and leadership
PhaseV receives three industry honours for AI in clinical development
Galapagos plans to wind down cell therapy business following strategic review
Sebela's MIUDELLA Hormone-Free Copper IUS recognised in TIME's best inventions of 2025
Revelation Pharma acquires Acacia Apothecary & Wellness
Viatris receives fifth consecutive recognition on Forbes' annual list of World's Best Employers